BioStem (BSEM) Director Jodi Ungrodt Receives Shares via RSU Vesting

What Happened
Director Jodi Ungrodt converted restricted stock units into common shares on August 27, 2026. The filing shows 5,647 shares acquired at $0.00 and 5,647 shares disposed at $0.00 (net cash effect $0). The transactions are reported under code M (exercise/conversion of a derivative).

Key Details

• Transaction date: 2026-08-27; Filing date: 2026-08-28 (timely reporting).
• Reported entries: 5,647 shares acquired @ $0.00; 5,647 shares disposed @ $0.00.
• Shares owned after transaction: not specified in this Form 4.
• Footnotes: F1 — each RSU converts to one common share; F2 — the RSUs vested in two installments (first on 2026-05-27; remaining on 2026-08-27).
• Exhibit/Remark: Exhibit 24 (Power of Attorney) included.

Context
This is a conversion/vesting event for RSUs rather than an open-market buy or sale. The matching acquisition and disposition on the same day is typical when shares are issued on vesting and an equal number are surrendered or withheld (commonly to cover taxes or other withholding obligations); the Form 4 shows $0 cash value for both legs. This filing is informational about compensation vesting, not necessarily a directional insider trade.